Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

• Status: Completed
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis
• Treatments: Fluvastatin

Criteria

Inclusion Criteria:

• Mixed dyslipidemia

• Primary hypercholesterolemia

Exclusion Criteria:

• Pregnant or lactating women

• Age > 18 years

Other protocol-defined inclusion and exclusion criteria may apply.